BIONANO GENOMICS INC (BNGO) Stock Price, Quote, News and Overview
NASDAQ:BNGO - Nasdaq - US09075F3055 - Common Stock - Currency: USD
BNGO Quote, Performance and Key Statistics
4.16
-0.22 (-5.02%)
The current stock price of BNGO is 4.16 USD. In the past month the price decreased by -27.65%. In the past year, price decreased by -94.45%.
BNGO Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.2 | 202.33B | ||
| DHR | DANAHER CORP | 27.74 | 149.40B | ||
| A | AGILENT TECHNOLOGIES INC | 24.09 | 36.49B | ||
| IQV | IQVIA HOLDINGS INC | 16.95 | 33.25B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 30.92 | 26.63B | ||
| WAT | WATERS CORP | 31.79 | 22.41B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 34.42 | 16.83B | ||
| ICLR | ICON PLC | 13.57 | 15.69B | ||
| ILMN | ILLUMINA INC | 36.22 | 14.07B | ||
| RVTY | REVVITY INC | 22.89 | 13.65B | ||
| AVTR | AVANTOR INC | 16.7 | 11.37B | ||
| MEDP | MEDPACE HOLDINGS INC | 25.92 | 9.97B |
Related stock screener links
About BNGO
Company Profile
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The company is headquartered in San Diego, California and currently employs 344 full-time employees. The company went IPO on 2018-08-01. The firm offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. The company also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The firm additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The firm markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
Company Info
BIONANO GENOMICS INC
9640 Towne Centre Drive, 9640 Towne Centre Drive
San Diego CALIFORNIA 92121 US
CEO: R. Erik Holmlin
Employees: 344
Company Website: https://bionano.com/
Investor Relations: https://ir.bionanogenomics.com/
Phone: 18588887600
BIONANO GENOMICS INC / BNGO FAQ
What is the stock price of BIONANO GENOMICS INC today?
The current stock price of BNGO is 4.16 USD. The price decreased by -5.02% in the last trading session.
What is the ticker symbol for BIONANO GENOMICS INC stock?
The exchange symbol of BIONANO GENOMICS INC is BNGO and it is listed on the Nasdaq exchange.
On which exchange is BNGO stock listed?
BNGO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BIONANO GENOMICS INC stock?
9 analysts have analysed BNGO and the average price target is 61.2 USD. This implies a price increase of 1371.15% is expected in the next year compared to the current price of 4.16. Check the BIONANO GENOMICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIONANO GENOMICS INC worth?
BIONANO GENOMICS INC (BNGO) has a market capitalization of 7.07M USD. This makes BNGO a Nano Cap stock.
How many employees does BIONANO GENOMICS INC have?
BIONANO GENOMICS INC (BNGO) currently has 344 employees.
What are the support and resistance levels for BIONANO GENOMICS INC (BNGO) stock?
BIONANO GENOMICS INC (BNGO) has a resistance level at 4.75. Check the full technical report for a detailed analysis of BNGO support and resistance levels.
Is BIONANO GENOMICS INC (BNGO) expected to grow?
The Revenue of BIONANO GENOMICS INC (BNGO) is expected to decline by -19.94% in the next year. Check the estimates tab for more information on the BNGO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIONANO GENOMICS INC (BNGO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BNGO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BNGO, evaluating the profitability, health, valuation and growth aspects
- BIONANO GENOMICS INC (BNGO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIONANO GENOMICS INC (BNGO) Sales and EPS estimates to see what analysts future expectations are.
- BIONANO GENOMICS INC (BNGO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIONANO GENOMICS INC (BNGO) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIONANO GENOMICS INC (BNGO) Stock Chart to make your own analysis
- BIONANO GENOMICS INC (BNGO) Latest news and press-releases to stay up to date.
Does BIONANO GENOMICS INC (BNGO) stock pay dividends?
BNGO does not pay a dividend.
When does BIONANO GENOMICS INC (BNGO) report earnings?
BIONANO GENOMICS INC (BNGO) will report earnings on 2025-03-03, after the market close.
What is the Price/Earnings (PE) ratio of BIONANO GENOMICS INC (BNGO)?
BIONANO GENOMICS INC (BNGO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-68.21).
BNGO Technical Analysis
BNGO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNGO. Both the profitability and financial health of BNGO have multiple concerns.
BNGO Financial Highlights
Over the last trailing twelve months BNGO reported a non-GAAP Earnings per Share(EPS) of -68.21. The EPS decreased by -1339.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -155.43% | ||
| ROE | -277.86% | ||
| Debt/Equity | 0.07 |
BNGO Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 49% to BNGO. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -2022.13% and a revenue growth -19.94% for BNGO